Kazakhstan Proposed Collective Medicine Procurement
The initiative aims to pool resources across Turkic states to lower costs and improve drug access.
Updated on Oct. 2, 2026 in Healthcare
Live Poll
Should nations form regional groups to jointly negotiate lower prices for medicine and medical supplies?
Kazakhstan has proposed a collective medicine procurement mechanism for members of the Organization of Turkic States. The plan intends to leverage joint negotiations to lower costs and improve drug safety for participating nations.
Why it matters
By pooling procurement needs, member states can improve medicine access and reduce costs through increased bargaining power with manufacturers. The model is based on Kazakhstan's existing centralized procurement infrastructure, which has already generated significant savings.
The proposal cites potential savings of $628,000 for Kyrgyzstan across 17 drugs, representing a 55% cost reduction. Kazakhstan has previously utilized its centralized system to save $151.1 million, or 68 billion tenge, in procurement costs.
The players
Organization of Turkic States
This intergovernmental organization consists of member states seeking to promote comprehensive cooperation in the Turkic world.
SK-Pharmacy LLP
This is the single distributor for the procurement and supply of medicines in Kazakhstan.
World Health Organization
This is the specialized agency of the United Nations responsible for international public health.
The details
Proposed during the Sixth Meeting of Health Ministers in Bishkek, the initiative utilizes the existing infrastructure of SK-Pharmacy LLP, which has managed centralized medical procurement since 2009. The plan also includes an accelerated drug registration procedure for members holding a third-level WHO maturity rating, such as Kazakhstan and Türkiye.
Timeline
2009: SK-Pharmacy LLP began managing centralized medical procurement.
First half of 2026: 2.75 million patients received free medicine in Kazakhstan.
2026: Kazakhstan reached a third-level WHO maturity rating for medicine regulation.
Market Landscape
This proposal reflects a broader move toward regional healthcare consolidation as nations seek to leverage shared infrastructure to mitigate rising pharmaceutical costs. By integrating with the WHO Global Benchmarking Tool, the initiative aligns regional procurement standards with established international regulatory frameworks.
Patients in participating nations may see improved medicine availability and potentially lower out-of-pocket costs due to more efficient procurement. The standardized registration process could also expedite the arrival of new, essential pharmaceutical products in member markets.
The takeaway
Regional cooperation on medical procurement can serve as a powerful tool for developing nations to exert greater control over pharmaceutical spending. Implementing such systems requires harmonized regulatory standards to ensure that safety and quality are maintained during the transition to joint purchasing.
Further reading
Learn more about the latest trends in the Healthcare sector.
Source note: This article includes information reported by Qazinform.
Live Poll
Should nations form regional groups to jointly negotiate lower prices for medicine and medical supplies?
